About Global BioAccess Fund
Global BioAccess Fund invests in transformative technologies that address serious unmet medical needs in oncology, rare disease, CNS, and cardiology. The company supports early-stage companies that need capital for IND submission and clinical trials. Global BioAccess Fund was founded in 2021 and is based in New York, New York.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Financial Services, Healthcare, VR/AR
Investor Type
Venture Capital
Investment Focus
Focus Areas
Investment Stages